Sangamo Therapeutics Inc. (SGMO) revealed Loss for fourth quarter of -$23.4 million
The company's bottom line totaled -$23.4 million, or -$0.11 per share. This compares with -$60.3 million, or -$0.34 per share, last year.
The company's revenue for the period rose 270.1% to $7.55 million from $2.04 million last year.
Sangamo Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$23.4 Mln. vs. -$60.3 Mln. last year.
-EPS: -$0.11 vs. -$0.34 last year.
-Revenue: $7.55 Mln vs. $2.04 Mln last year.
For comments and feedback: editorial@rttnews.com